| Bioactivity | Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria. | ||||||||||||
| Invitro | Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL[1]. Midecamycin is a 16-membered macrolide. Midecamycin is a new macrolide antibiotic, which is produced by Streptomyces mycarofaciens[2]. | ||||||||||||
| Name | Midecamycin | ||||||||||||
| CAS | 35457-80-8 | ||||||||||||
| Formula | C41H67NO15 | ||||||||||||
| Molar Mass | 813.97 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Midecamycin
CAS: 35457-80-8 F: C41H67NO15 W: 813.97
Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.